Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1521213
PUBLISHER: IMARC | PRODUCT CODE: 1521213
Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global anti-obesity drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.
Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They help reduce cravings and control compulsive eating, especially for sweets and fatty, salty, and high-calorie food products. They can also provide independent health benefits, such as controlling blood pressure, harmful lipid levels, waist circumference, sugar levels and nonalcoholic fatty liver disease (NAFLD) and minimize the risk of major cardiovascular diseases (CVDs) and progression of diabetic kidney disease.
Anti-Obesity Drugs Market Trends:
Recent advances in anti-obesity drugs have enabled the potential of attaining clinically significant weight loss among individuals. This, in confluence with the widespread prevalence of obesity on account of sedentary lifestyles, represents one of the key factors creating a positive outlook for the market. In addition, obesity increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases (CVD), and cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. It can also result in numerous psychological, neurological, pulmonary, gastrointestinal, renal, musculoskeletal, and endocrine diseases. Besides this, sleep deprivation, circadian desynchronization, chronic stress, and the rising use of anti-epileptic and psychotropic drugs may further induce weight gain. This, coupled with the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings, is fueling the growth of the market. Apart from this, weight loss aids in improving the quality of life, mobility, daily function, and psychological well-being of individuals. This, along with the increasing health consciousness, thriving pharmaceutical industry, and the rising focus on the management of diseases closely integrated with excess body weight, is anticipated to stimulate the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-obesity drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, drug type, and distribution channel.
Breakup by Drug Class:
Peripherally Acting Drugs
Centrally Acting Drugs
Breakup by Drug Type:
Prescription Drugs
OTC Drugs
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, Gelesis, GlaxoSmithKline plc, Merck & Co. Inc., Norgine B.V., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals Inc., SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Vivus LLC.
Key Questions Answered in This Report
- 1. What was the size of the global anti-obesity drugs market in 2023?
- 2. What is the expected growth rate of the global anti-obesity drugs market during 2024-2032?
- 3. What are the key factors driving the global anti-obesity drugs market?
- 4. What has been the impact of COVID-19 on the global anti-obesity drugs market?
- 5. What is the breakup of the global anti-obesity drugs market based on the drug class?
- 6. What is the breakup of the global anti-obesity drugs market based on the drug type?
- 7. What is the breakup of the global anti-obesity drugs market based on distribution channel?
- 8. What are the key regions in the global anti-obesity drugs market?
- 9. Who are the key players/companies in the global anti-obesity drugs market?
Product Code: SR112024A5544
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anti-Obesity Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 Peripherally Acting Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Centrally Acting Drugs
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Prescription Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 OTC Drugs
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Pharmacy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Boehringer Ingelheim International GmbH
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Currax Pharmaceuticals LLC
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Gelesis
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 GlaxoSmithKline plc
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Merck & Co. Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Norgine B.V.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Novo Nordisk A/S
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Rhythm Pharmaceuticals Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.10 SHIONOGI & Co. Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Vivus LLC
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Boehringer Ingelheim International GmbH
Product Code: SR112024A5544
List of Figures
- Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2023
- Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2023
- Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2023
- Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Anti-Obesity Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Anti-Obesity Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Anti-Obesity Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Anti-Obesity Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Anti-Obesity Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Anti-Obesity Drugs (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Anti-Obesity Drugs (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: North America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: North America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: United States: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: United States: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Canada: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Canada: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Asia-Pacific: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Asia-Pacific: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: China: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: China: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Japan: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Japan: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: India: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: India: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: South Korea: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: South Korea: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Australia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Australia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Indonesia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Indonesia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Europe: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Europe: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Germany: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Germany: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: France: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: France: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: United Kingdom: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: United Kingdom: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Italy: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Italy: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Spain: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Spain: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Russia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Russia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Latin America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Latin America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Brazil: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Brazil: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Mexico: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Mexico: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Middle East and Africa: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Middle East and Africa: Anti-Obesity Drugs Market: Breakup by Country (in %), 2023
- Figure 70: Middle East and Africa: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Global: Anti-Obesity Drugs Industry: SWOT Analysis
- Figure 72: Global: Anti-Obesity Drugs Industry: Value Chain Analysis
- Figure 73: Global: Anti-Obesity Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Anti-Obesity Drugs Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
- Table 3: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
- Table 4: Global: Anti-Obesity Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 5: Global: Anti-Obesity Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Anti-Obesity Drugs Market: Competitive Structure
- Table 7: Global: Anti-Obesity Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.